• About us
• Contact

Advertisement

Person › Details

Jean-Christophe Tellier (UCB S.A. (Euronext: UCB))

Tellier, Jean-Christophe (UCB 201403– CEO-elect joined UCB 2011 before Ipsen + Macrogenics + Novartis)

 

	Organisation	UCB S.A. (Euronext: UCB)
	Group	UCB (Group)
	Product	pharmaceutical
	Product 2	CNS drug (neurological drug)

Record changed: 2023-03-13

Advertisement

More documents for Jean-Christophe Tellier

• [1] UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels....
• [2] UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels....
• [3] UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA....
• [4] UCB S.A.. (2/28/19). "Press Release: UCB Full Year Report 2018. 2018 Marks the Fifth Consecutive Year of Profitable Growth, Intensifying Investment in UCB’s Strong Pipeline". Brussels....
• [5] UCB S.A.. (4/25/18). "Press Release: UCB First Three Months Interim Report 2018. UCB Tracking Well towards Full Year Financial Outlook". Brussels....
• [6] UCB S.A.. (4/20/18). "Press Release: UCB to Expand Epilepsy Portfolio with Strategic Acquisition of Midazolam Nasal Spray from Proximagen". Brussels....
• [7] UCB S.A.. (10/20/17). "Press Release: UCB First Nine Months Interim Report 2017 – Strong 9 Months Performance Allows for Increase of 2017 Financial Outlook". Brussels....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.